SCHEMBL7216265

SCHEMBL7216265

CCOc1ccc(NC(=O)c2c[nH]c3c2-c2nn(C)cc2CCC3)nc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
ALDH1A1 P00352 2/20 0.37
HTT P42858 1/20 0.37
MAPT P10636 5/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
CASP1 P29466 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
AURKA O14965 2/20 0.35
NR3C1 P04150 1/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SCN9A Q15858 1/20 0.33
TP53 P04637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7216813 0.91 F10 (0.39) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL7217055 0.89 NPC1 (0.48) NPC1RAB9AHTTMAPTSMN1; SMN2
SCHEMBL7222852 0.87 NPC1 (0.43) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL7216469 0.83 NPC1 (0.42) NPC1RAB9AHTTMAPTSMN1; SMN2
SCHEMBL6095975 0.82 MAPT (0.40) NPC1RAB9AALDH1A1HTTMAPT
SCHEMBL6834487 0.82 GAA (0.43) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL6834466 0.80 KMT2A (0.37) NPC1RAB9AALDH1A1HTTMAPT
SCHEMBL7216803 0.78 NR3C1 (0.41) NPC1RAB9AALDH1A1HTTMAPT
SCHEMBL7216549 0.78 ROCK2 (0.37) NPC1RAB9ALMNAAURKANR3C1
SCHEMBL7218324 0.77 MAPT (0.42) NPC1RAB9AALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653471-B2 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction NEUROGEN CORPORATION 2003-11-25 US disclosed